Clinical Trial Update: A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating YM178 for overactive bladder has completed, with safety and efficacy assessments conducted in patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• YM178

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED